Key facts
- M2Care’s last known valuation is $2.8M (Jun 2023).
- It has raised $52.7M; the latest was Later Stage VC ($30.3M) in Sep 2025.
- Notable investors include Bpifrance, Crédit Agricole Centre Loire, César Berthier, Dominique Gayrard, Merieux Equity Partners (Lyon) — 8 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 8 names
- ·Watchlist + deal alerts for M2Care
- ·The full record, as it builds
Funding rounds
No funding rounds for M2Care are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About M2Care
Operator of a venture studio intended to develop innovations that address major health challenges. The company tests the feasibility and viability of projects, creates and invests in healthcare startups, recruits and allocates human resources to projects, and promotes market access, helping startups secure funding and ensure they are positioned for growth and strategic acquisition.
- Sector
- Financial Services
- HQ
- Lyon, France
- Founded
- 2017
- Employees
- 9
- Website
- m2.care/
- Ownership
- Privately Held (backing)
M2Care doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in M2Care shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on M2Care in its N-PORT filings yet. We sweep new filings monthly.